Efficacy and Mortality of a Loading Dose of Colistin in Critical Ill Patients
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The study hypothesis is that the loading dose of intravenous colistin (6 million of
international units) is associated with greater clinical and microbiological efficacy, and
reduced mortality of critically ill patients infected by multidrug resistant Gram- negative
bacilli, compared to a scheme without loading dose.
Phase:
Phase 4
Details
Lead Sponsor:
Hospital Barros Luco Trudeau
Collaborator:
Fondo Nacional de Desarrollo Científico y Tecnológico, Chile